All 152 XBI (SPDR(R) S&P(R) BIOTECH ETF) Holdings
There are 152 XBI holdings. Top 10 companies weight: 15.41%.
Total Market Cap: $1.54T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (152 stocks) | +11.38% | 28.98 | 15.04 | 0.45 | +35.29% | +12.59% | 0.70 | ||||||||||
51 | MRNA | Moderna Inc | 0.97% | $45.64 | $19B | Biotechnology | Healthcare | N/A | N/A | 23.04 | N/A | N/A | N/A | 48 | -5.35% | $43 | -25.22% | 1.37 |
52 | CPRX | Catalyst Pharmaceuticals Inc | 0.97% | $31.27 | $3.83B | Biotechnology | Healthcare | +20.98% | 17.34 | 12.87 | 1.72 | N/A | N/A | 75 | +4.25% | $33 | +41.56% | 0.89 |
53 | IRON | Disc Medicine Inc Ordinary Shares | 0.94% | $68 | $2.66B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +48.66% | $101 | -11.63% | 1.16 |
54 | REGN | Regeneron Pharmaceuticals Inc | 0.94% | $602.92 | $65B | Biotechnology | Healthcare | +20.31% | 14.98 | 13.39 | 83.17 | N/A | N/A | 72 | +38.21% | $833 | +3.75% | 0.64 |
55 | INSM | Insmed Inc | 0.90% | $103.73 | $23B | Biotechnology | Healthcare | +12.24% | N/A | 16.37 | 1.09 | N/A | N/A | 79 | +92.81% | $200 | +32.74% | 0.74 |
56 | VERA | Vera Therapeutics Inc Class A | 0.89% | $31.26 | $2.45B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +149.52% | $78 | +16.05% | 1.25 |
57 | IMNM | Immunome Inc Ordinary Shares | 0.88% | $19.34 | $2.50B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +82.83% | $35 | -0.06% | 1.69 |
58 | DYN | Dyne Therapeutics Inc Ordinary Shares | 0.85% | $17.24 | $3B | Biotechnology | Healthcare | N/A | N/A | N/A | 0.19 | N/A | N/A | 76 | +121.87% | $38 | -0.88% | 1.83 |
59 | BCRX | Biocryst Pharmaceuticals Inc | 0.77% | $8.34 | $2.32B | Drug Manufacturers - Specialty & Generic | Healthcare | +6.24% | N/A | 74.63 | N/A | N/A | N/A | 82 | +155.40% | $21 | -12.61% | 0.79 |
60 | DNLI | Denali Therapeutics Inc | 0.75% | $19.35 | $3.21B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +75.35% | $34 | -21.40% | 1.56 |
61 | AGIO | Agios Pharmaceuticals Inc | 0.74% | $26.51 | $1.70B | Biotechnology | Healthcare | N/A | N/A | 2.47 | N/A | N/A | N/A | 67 | +54.21% | $41 | -14.24% | 1.09 |
62 | ERAS | Erasca Inc | 0.74% | $13.48 | $3.88B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 70 | +50.59% | $20 | 0.00% | 1.30 |
63 | MLYS | Mineralys Therapeutics Inc | 0.72% | $28.85 | $2.47B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +68.11% | $49 | 0.00% | 0.78 |
64 | RCUS | Arcus Biosciences Inc | 0.71% | $24.47 | $3.01B | Biotechnology | Healthcare | +14.36% | N/A | N/A | N/A | N/A | N/A | 68 | +42.30% | $35 | -0.26% | 1.50 |
65 | DNTH | Dianthus Therapeutics Inc | 0.69% | $81.57 | $4.73B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00% | N/A |
66 | SRPT | Sarepta Therapeutics Inc | 0.69% | $16.25 | $1.76B | Biotechnology | Healthcare | N/A | 4.62 | 5.73 | 159.25 | N/A | N/A | 51 | +35.38% | $22 | -26.11% | 1.39 |
67 | RXRX | Recursion Pharmaceuticals Inc Class A | 0.68% | $3.61 | $1.68B | Biotechnology | Healthcare | -10.03% | N/A | N/A | N/A | N/A | N/A | 65 | +83.93% | $6.64 | -33.81% | 2.60 |
68 | NRIX | Nurix Therapeutics Inc Ordinary Shares | 0.66% | $16.37 | $1.81B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 82 | +84.36% | $30 | -11.32% | 1.35 |
69 | KOD | Kodiak Sciences Inc | 0.66% | $33.22 | $2.18B | Biotechnology | Healthcare | +4.23% | N/A | N/A | N/A | N/A | N/A | 75 | +88.68% | $63 | -15.75% | 1.73 |
70 | NVAX | Novavax Inc | 0.66% | $10.21 | $1.82B | Biotechnology | Healthcare | -42.97% | N/A | 2.59 | 1.32 | N/A | N/A | 50 | +38.20% | $14 | -43.27% | 1.50 |
71 | ARDX | Ardelyx Inc | 0.65% | $5.52 | $1.52B | Biotechnology | Healthcare | -26.76% | N/A | 40.65 | N/A | N/A | N/A | 77 | +195.83% | $16 | -4.31% | 0.82 |
72 | IDYA | Ideaya Biosciences Inc | 0.65% | $27.87 | $2.57B | Biotechnology | Healthcare | +8.12% | N/A | 4.65 | N/A | N/A | N/A | 76 | +85.47% | $52 | +6.44% | 1.11 |
73 | NTLA | Intellia Therapeutics Inc | 0.64% | $13.13 | $1.62B | Biotechnology | Healthcare | +8.10% | N/A | N/A | N/A | N/A | N/A | 62 | +102.82% | $27 | -28.75% | 1.70 |
74 | SNDX | Syndax Pharmaceuticals Inc | 0.63% | $18.39 | $1.74B | Biotechnology | Healthcare | +12.13% | N/A | N/A | N/A | N/A | N/A | 78 | +113.43% | $39 | +0.53% | 1.07 |
75 | VRDN | Viridian Therapeutics Inc | 0.62% | $15.87 | $1.77B | Biotechnology | Healthcare | -32.36% | N/A | 1.01 | N/A | N/A | N/A | 77 | +113.86% | $34 | -0.90% | 1.10 |
76 | ORKA | Oruka Therapeutics Inc | 0.61% | $55.23 | $2.91B | Biotechnology | Healthcare | +11.91% | N/A | N/A | N/A | N/A | N/A | 78 | +157.41% | $142 | +15.52% | N/A |
77 | QURE | Uniqure Nv | 0.58% | $26.76 | $1.59B | Biotechnology | Healthcare | +2.11% | N/A | 27.93 | N/A | N/A | N/A | 69 | +46.38% | $39 | -5.16% | 1.33 |
78 | RLAY | Relay Therapeutics Inc Ordinary Shares | 0.55% | $15.70 | $2.73B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +54.46% | $24 | -13.31% | 1.84 |
79 | ADMA | Adma Biologics Inc | 0.55% | $7.60 | $1.84B | Biotechnology | Healthcare | N/A | 11.33 | 9.61 | N/A | N/A | N/A | 68 | +120.39% | $17 | +34.45% | 1.25 |
80 | TNGX | Tango Therapeutics Inc | 0.54% | $21.50 | $2.83B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +48.37% | $32 | +14.39% | 1.35 |
81 | MNKD | Mannkind Corp | 0.53% | $3.43 | $1.10B | Biotechnology | Healthcare | -21.18% | N/A | 37.31 | 4.39 | N/A | N/A | 71 | +121.28% | $7.59 | -2.03% | 0.72 |
82 | BHVN | Biohaven Ltd | 0.53% | $10.12 | $1.70B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 73 | +114.53% | $22 | 0.00% | 1.53 |
83 | VCEL | Vericel Corp | 0.53% | $34.45 | $1.75B | Biotechnology | Healthcare | +35.66% | 80.63 | 68.97 | 0.14 | N/A | N/A | 71 | +60.90% | $55 | -8.84% | 1.19 |
84 | SLS | Sellas Life Sciences Group Inc | 0.52% | $8.33 | $1.56B | Biotechnology | Healthcare | -32.56% | N/A | N/A | N/A | N/A | N/A | 87 | +20.05% | $10 | -5.24% | 0.85 |
85 | CLDX | Celldex Therapeutics Inc | 0.51% | $28.90 | $2.11B | Biotechnology | Healthcare | +21.48% | N/A | N/A | N/A | N/A | N/A | 76 | +102.18% | $58 | +0.58% | 1.16 |
86 | GLUE | Monte Rosa Therapeutics Inc | 0.51% | $17.74 | $1.62B | Biotechnology | Healthcare | N/A | N/A | 10.02 | N/A | N/A | N/A | 81 | +82.24% | $32 | 0.00% | 1.35 |
87 | STOK | Stoke Therapeutics Inc | 0.48% | $28.68 | $1.96B | Biotechnology | Healthcare | +11.95% | N/A | 204.08 | N/A | N/A | N/A | 77 | +57.25% | $45 | -5.78% | 1.09 |
88 | CAPR | Capricor Therapeutics Inc | 0.47% | $27.34 | $1.68B | Biotechnology | Healthcare | +22.65% | N/A | 78.74 | N/A | N/A | N/A | 80 | +97.92% | $54 | +47.62% | 1.46 |
89 | OLMA | N/A | 0.46% | $10.69 | $1.13B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +291.21% | $42 | -17.30% | 0.70 |
90 | IOVA | Iovance Biotherapeutics Inc | 0.45% | $4.10 | $1.91B | Biotechnology | Healthcare | -12.60% | N/A | N/A | N/A | N/A | N/A | 75 | +114.63% | $8.80 | -25.12% | 1.66 |
91 | PVLA | Palvella Therapeutics Inc | 0.44% | $104.67 | $1.66B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +119.32% | $230 | 0.00% | 1.01 |
92 | INBX | Inhibrx Biosciences Inc | 0.43% | $93.63 | $1.50B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 62 | +196.38% | $278 | 0.00% | 1.39 |
93 | CDNA | Caredx Inc | 0.43% | $22.07 | $1.14B | Diagnostics & Research | Healthcare | -10.97% | N/A | 94.34 | N/A | N/A | N/A | 60 | +16.90% | $26 | -22.71% | 1.31 |
94 | TSHA | N/A | 0.43% | $5.69 | $1.65B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +114.94% | $12 | -23.73% | 1.40 |
95 | ANAB | Anaptysbio Inc | 0.40% | $51.26 | $1.67B | Biotechnology | Healthcare | -4.15% | N/A | N/A | N/A | N/A | N/A | 79 | +64.75% | $84 | +26.40% | 0.81 |
96 | KALV | Kalvista Pharmaceuticals Inc | 0.39% | $26.94 | $1.37B | Biotechnology | Healthcare | +11.29% | N/A | 25.45 | N/A | N/A | N/A | 60 | +6.16% | $29 | +0.41% | 0.87 |
97 | CRVS | Corvus Pharmaceuticals Inc | 0.37% | $11.69 | $1.09B | Biotechnology | Healthcare | +53.96% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | +34.16% | N/A |
98 | KURA | Kura Oncology Inc | 0.36% | $8.97 | $909M | Biotechnology | Healthcare | +15.40% | N/A | N/A | N/A | N/A | N/A | 76 | +247.49% | $31 | -15.97% | 1.07 |
99 | PGEN | Precigen Inc | 0.35% | $3.86 | $1.55B | Biotechnology | Healthcare | -3.77% | N/A | 204.08 | N/A | N/A | N/A | 75 | +222.54% | $12 | -10.09% | 1.67 |
100 | ABSI | Absci Corp | 0.33% | $6.35 | $789M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +38.43% | $8.79 | 0.00% | 2.25 |
XBI (SPDR(R) S&P(R) BIOTECH ETF) Sector Allocation
HEALTHCARE
96.80%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%